Insider · CIK 0001886986
Blake Aftab
officer
Files at ACET (Adicet Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | ACET Adicet Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +72,555 | $0.00 | $0 | 72,555 | Mar 27, 2026 |
| Jan 24, 2026 | ACET Adicet Bio, Inc. | FTax withholding Common Stock | -535 | $8.44 | $4,515 | 2,981 | Jan 27, 2026 |
| Jan 31, 2025 | ACET Adicet Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Feb 4, 2025 |
| Jan 24, 2025 | ACET Adicet Bio, Inc. | FTax withholding Common Stock | -6,270 | $0.92 | $5,780 | 56,241 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.